NUVATION BIO INC (NUVB) Stock Analyst Ratings
NYSE:NUVB - New York Stock Exchange, Inc. - US67080N1019 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to NUVB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.99. This target is 350.14% above the current price.
NUVB was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NUVB.
In the previous month the buy percentage consensus was at a similar level.
NUVB was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-23 | JMP Securities | Initiate | Market Outperform |
| 2025-03-12 | Jones Trading | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-03-27 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-26 | BTIG | Upgrade | Neutral -> Buy |
| 2024-03-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |